Latest Innovation News

Cardiex Limited has gained Therapeutic Goods Administration approval for its CONNEQT Pulse device, paving the way for commercial expansion in Australia alongside its established US presence.

Ioneer Ltd has announced a 308% increase in the Ore Reserve for its Rhyolite Ridge Lithium-Boron Project in Nevada, extending mine life to 95 years and confirming robust economics with low-cost lithium production and a stable boric acid revenue stream.

Bio-Gene Technology Limited has raised $338,500 through a Share Purchase Plan, contributing to a total capital raise of $2.45 million to advance its bio-insecticide products.

Volt Resources has reshaped its executive team to sharpen focus on downstream graphite refining and advanced materials, appointing Trevor Matthews to its board while repositioning CEO Prashant Chintawar.

HITIQ has secured a pivotal one-year deal with the South Metro Junior Football League, positioning its PROTEQT concussion management system at the heart of junior sports safety. This move complements existing partnerships and signals a strong push into Australia’s grassroots sports market.

ReNerve Limited has entered a strategic partnership with Berkeley Biologics to develop and commercialise two new tissue-based product ranges, aiming to expand its footprint in the US surgical market by the end of 2025.

Hydralyte USA reports its best EBITDA performance since IPO, driven by strong sales and cost reductions, setting the stage for growth with upcoming product launches.

Green Critical Minerals has raised A$7 million through an institutional placement to accelerate the commercial rollout of its Very High Density graphite technology, aiming for first revenue in early 2026.

Radiopharm Theranostics has unveiled encouraging preclinical results for its Lu177-B7H3 monoclonal antibody, RV01, paving the way for a mid-2025 Investigational New Drug submission and a Phase 1 trial later that year.

Iondrive Limited is expanding its proprietary Deep Eutectic Solvent technology into the burgeoning e-waste urban mining sector, backed by a South Australian government grant. The company aims to recover valuable metals from printed circuit boards, tapping into a global market worth billions yet largely unrecycled.

Lumos Diagnostics has reached 50% recruitment of bacterial positive patients in its pivotal FebriDx CLIA waiver clinical study, setting the stage for a planned FDA submission in late 2025 and unlocking a substantial US market opportunity.

Atturra Limited has completed its acquisition of DalRae Solutions, a specialist SAP consultancy, aiming to deepen its footprint in SAP services across Australia and New Zealand. The deal includes upfront and performance-based payments totalling up to $20 million.